Search

Your search keyword '"Gullestad, Lars"' showing total 1,605 results

Search Constraints

Start Over You searched for: Author "Gullestad, Lars" Remove constraint Author: "Gullestad, Lars"
1,605 results on '"Gullestad, Lars"'

Search Results

1. Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity

2. Neutrophil Extracellular Traps in ST-Segment Elevation Myocardial Infarction: Reduced by Tocilizumab and Associated With Infarct Size

3. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

5. A Clinical Evaluation of a Low-Cost Strain Gauge Respiration Belt and Machine Learning to Detect Sleep Apnea

6. Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis

11. Abstract 18428: Effect of Continuous Positive Airway Pressure on Atrial Remodeling in Patients With Obstructive Sleep Apnea and Paroxysmal Atrial Fibrillation; a Randomized Controlled Trial

14. Regulation of cardiomyocyte t‐tubule structure by preload and afterload: Roles in cardiac compensation and decompensation

16. Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: A randomized controlled trial

18. Circular RNA Profile in Atherosclerotic Disease: Regulation during ST-Elevated Myocardial Infarction.

20. Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis

22. NT-proBNP for Risk Prediction in Heart Failure: Identification of Optimal Cutoffs Across Body Mass Index Categories

23. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

24. Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction

25. Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction

26. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

27. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

30. Invasive haemodynamics at rest and exercise in cardiac amyloidosis.

32. Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages

33. Long-Term Outcomes of Invasive vs Conservative Strategies for Older Patients With Non–ST-Segment Elevation Acute Coronary Syndromes

34. Prognostic value of intravascular ultrasound early after heart transplantation

40. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

42. Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction

43. sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T

44. Non-invasive myocardial work in aortic stenosis: validation and improvement in left ventricular pressure estimation.

47. Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab

49. YKL-40 (Chitinase-3-Like Protein 1) Serum Levels in Aortic Stenosis

Catalog

Books, media, physical & digital resources